Researchers identify biomarkers for selecting AMD patients for TES protocol ByMichelle Dalton, ELSJanuary 31st 2020
Research targets gene therapy for exudative AMD patientsByCheryl Guttman Krader, BS, PharmDecember 11th 2019
Is deep learning the future of diabetic retinopathy screening?ByMichelle Dalton, ELSDecember 11th 2019
Early intervention best for patients with diabetic eye diseasesByMichelle Dalton, ELSNovember 20th 2019
Ultra-widefield OCT ‘may be the only imaging’ needed to manage PDRByMichelle Dalton, ELSNovember 15th 2019
Anti-VEGF injections and glaucoma: Surgeons must watch IOP elevation ByLouise GagnonNovember 12th 2019
Central subfield thickness only partially responsible for changes in acuityByMichelle Dalton, ELSNovember 7th 2019
AMD risk phenotypes targeted in direct-to-consumer genetic databaseByCheryl Guttman Krader, BS, PharmNovember 4th 2019
AI model predicts future DR progression in individual patientsByMichelle Dalton, ELSNovember 1st 2019
SWAP-TWO shows anatomic improvement after switch to afliberceptByMichelle Dalton, ELSSeptember 17th 2019
ASRS 2019 Street Team: W. Lloyd Clark, MDByJulianne MobilianAugust 29th 2019ICYMI: Dr. Clark breaks down the results of the PANORAMA Study
ASRS 2019 Street Team: Rishi P. Singh, MDByOT Staff ReportsAugust 28th 2019ICYMI: Dr. Singh shares the take-home message from his 2019 presentation
ASRS 2019 Street Team: Charles C. Wykoff, MD, PhDByOT Staff ReportsAugust 28th 2019ICMYI: Dr. Wykoff discusses results from his ASRS presentation